Intrabody construction and expression. I. The critical role of VL domain stability.

We have constructed a panel of hyperstable immunoglobulin VL domains by a rational approach of consensus sequence engineering and combining stabilizing point mutations. These prototype domains unfold fully reversibly, even when the conserved structural disulfide bridge is reduced. This has allowed us to probe the factors that limit the expression yield of soluble immunoglobulin domains in the reducing environment of the cytoplasm (intrabodies). The most important factor is thermodynamic stability, and there is an excellent quantitative correlation between stability and yield. Surprisingly, an unprocessed N-terminal methionine residue can severely compromise VL stability, but this problem can be overcome by changing the amino acid following the initiator methionine residue. Transcription from the strong T7 promoter does not increase the amount of soluble material over that obtained from the tetA promoter, but large amounts of inclusions bodies can be obtained. Elevated temperature shifts protein from a productive folding pathway to aggregation. The structural disulfide bridge does not form in the cytoplasm, but the two consensus cysteine residues can be quantitatively oxidized in vitro. In summary, stability engineering provides a plannable route to the high-yield cytoplasmic expression of functional intrabody domains.

[1]  R. R. Robinson,et al.  Escherichia coli secretion of an active chimeric antibody fragment. , 1988, Science.

[2]  P. Wirtz,et al.  Intrabody construction and expression III: Engineering hyperstable VH domains , 2008, Protein science : a publication of the Protein Society.

[3]  A. Plückthun,et al.  Engineered turns of a recombinant antibody improve its in vivo folding. , 1995, Protein engineering.

[4]  E. Padlan,et al.  X-ray crystallography of antibodies. , 1996, Advances in protein chemistry.

[5]  A. Plückthun,et al.  Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. , 1988, Science.

[6]  P. Hudson,et al.  Recombinant antibody fragments. , 1998, Current opinion in biotechnology.

[7]  E. Pohl,et al.  Contribution of the intramolecular disulfide bridge to the folding stability of REIv, the variable domain of a human immunoglobulin kappa light chain. , 1996, Folding & design.

[8]  S. Steinbacher,et al.  β‐Turn propensities as paradigms for the analysis of structural motifs to engineer protein stability , 1997, Protein science : a publication of the Protein Society.

[9]  I. Pastan,et al.  Treatment of advanced solid tumors with immunotoxin LMB–1: An antibody linked to Pseudomonas exotoxin , 1996, Nature Medicine.

[10]  T. Scanlan,et al.  KINETIC AND MECHANISTIC CHARACTERIZATION OF AN EFFICIENT HYDROLYTIC ANTIBODY : EVIDENCE FOR THE FORMATION OF AN ACYL INTERMEDIATE , 1994 .

[11]  P. V. von Hippel,et al.  Calculation of protein extinction coefficients from amino acid sequence data. , 1989, Analytical biochemistry.

[12]  A. Plückthun,et al.  Antibody scFv fragments without disulfide bonds made by molecular evolution. , 1998, Journal of molecular biology.

[13]  G. Sheldrick,et al.  X-ray crystallography reveals stringent conservation of protein fold after removal of the only disulfide bridge from a stabilized immunoglobulin variable domain. , 1997, Folding & design.

[14]  J. Schellman Solvent denaturation , 1978 .

[15]  Y. Goto,et al.  Unfolding and refolding of the reduced constant fragment of the immunoglobulin light chain. Kinetic role of the intrachain disulfide bond. , 1982, Journal of molecular biology.

[16]  A. Skerra Use of the tetracycline promoter for the tightly regulated production of a murine antibody fragment in Escherichia coli. , 1994, Gene.

[17]  S. Steinbacher,et al.  Sequence statistics reliably predict stabilizing mutations in a protein domain. , 1994, Journal of molecular biology.

[18]  J. Barnikow,et al.  Intrabody construction and expression. II. A synthetic catalytic Fv fragment. , 1999, Journal of Molecular Biology.

[19]  H R Hoogenboom,et al.  Antibody phage display technology and its applications. , 1998, Immunotechnology : an international journal of immunological engineering.

[20]  E. Kabat,et al.  Sequences of proteins of immunological interest , 1991 .

[21]  L. T. Chen,et al.  Remarkable destabilization of recombinant alpha-lactalbumin by an extraneous N-terminal methionyl residue. , 1998, Protein engineering.

[22]  P. Martineau,et al.  Expression of an antibody fragment at high levels in the bacterial cytoplasm. , 1998, Journal of molecular biology.

[23]  E. Kremmer,et al.  Specific detection of his-tagged proteins with recombinant anti-His tag scFv-phosphatase or scFv-phage fusions. , 1997, BioTechniques.

[24]  C. Pace,et al.  Conformational stability and activity of ribonuclease T1 with zero, one, and two intact disulfide bonds. , 1988, The Journal of biological chemistry.

[25]  D. Mcnulty,et al.  Mutational effects on inclusion body formation in the periplasmic expression of the immunoglobulin VL domain REI. , 1996, Folding & design.

[26]  P. Dessen,et al.  Extent of N-terminal methionine excision from Escherichia coli proteins is governed by the side-chain length of the penultimate amino acid. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[27]  R. Schoepfer The pRSET family of T7 promoter expression vectors for Escherichia coli. , 1993, Gene.

[28]  R. Glockshuber,et al.  The disulfide bonds in antibody variable domains: effects on stability, folding in vitro, and functional expression in Escherichia coli. , 1992, Biochemistry.